Biliary Tract Cancer (BTC)

Oncology
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
1
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Alligator Bioscience
1 program
1
mFOLFOX regimenPhase 2/31 trial
Active Trials
NCT07437287Not Yet RecruitingEst. Oct 2031
TerSera Therapeutics
TerSera TherapeuticsIL - Deerfield
1 program
1
telotristat ethylPhase 21 trial
Active Trials
NCT03790111TerminatedEst. Jan 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Alligator BiosciencemFOLFOX regimen
TerSera Therapeuticstelotristat ethyl

Clinical Trials (2)

Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Tract Cancers

Start: Jul 2026Est. completion: Oct 2031
Phase 2/3Not Yet Recruiting

A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer

Start: Mar 2019Est. completion: Jan 2022
Phase 2Terminated

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space